| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 24 |
| 1 | ACETAMINOPHEN | 15 |
| 2 | ACETAMINOPHEN 500MG | 15 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 15 |
| 4 | PAIN RELIEVER | 15 |
| 5 | RIVAROXABAN | 14 |
| 6 | PREDNISONE | 13 |
| 7 | ALBUTEROL SULFATE | 12 |
| 8 | FUROSEMIDE | 12 |
| 9 | CISPLATIN | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHANOLAMINE OLEATE | 1 | 0.0556 |
| 1 | SEROTONIN | 4 | 0.0147 |
| 2 | BETAXOLOL | 7 | 0.0085 |
| 3 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 4 | BODY CLEANSER | 2 | 0.0028 |
| 5 | ETOMIDATE INJECTION | 6 | 0.0028 |
| 6 | ANTI-INHIBITOR COAGULANT COMPLEX | 3 | 0.0027 |
| 7 | ETOMIDATE | 6 | 0.0027 |
| 8 | OXACILLIN SODIUM | 2 | 0.0018 |
| 9 | AMIFOSTINE | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Dihydropyridine Calcium Channel Blocker [EPC] | 31 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 2 | Calcium Channel Blocker [EPC] | 24 |
| 3 | Corticosteroid [EPC] | 23 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 18 |
| 5 | Platinum-based Drug [EPC] | 17 |
| 6 | Factor Xa Inhibitor [EPC] | 15 |
| 7 | Microtubule Inhibitor [EPC] | 15 |
| 8 | Catecholamine [EPC] | 14 |
| 9 | Loop Diuretic [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 4 | 0.0004 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 4 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 5 | Cannabinoid [EPC] | 2 | 0.0002 |
| 6 | General Anesthetic [EPC] | 10 | 0.0002 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 8 | Nuclear Export Inhibitor [EPC] | 2 | 0.0002 |
| 9 | Thiazide-like Diuretic [EPC] | 8 | 0.0002 |